• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number SP-101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Edema (1820); Erythema (1840); Inflammation (1932); Pain (1994); Patient Problem/Medical Problem (2688)
Event Date 04/23/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the physician used the venaseal closure system to treat the great saphenous vein (gsv) and the anterior accessory great saphenous vein (aagsv).There were no complications with the procedure.The ifu was followed and the device was prepped without issue.Approximately 1 month post the procedure, the patient returned to the surgery with swelling along the course of the gsv.The patient was treated with antibiotics and heparin.It was reported that it improved except for inside of the knee which remained inflamed.Corticosteroids were prescribed and it was reported that this improved however, the patient has reported the pain and the edema has worsened.
 
Manufacturer Narrative
Additional information: the patient¿s thigh was treated with the venaseal closure system.The erythema was observed approximately 4 weeks post procedure.Patient first prescribed antibiotics approximately 4 months post-procedure.The patient returned to the surgery with swelling along the course of the great saphenous and anterior accessory vein (gsv).Approx 6 months post index, the patient was operated on for resection of skin, subcutaneous tissue and internal saphenous vein in the area of inflammation.The outcome is favorable.Image review one image was received for evaluation.Per the image, a blistered wound was observed on the patient skin.There is also evidence of redness on the patient wound.The sp-101 venaseal kit was not returned for evaluation.The customer experience of patient allergic reaction post procedure was confirmed based on the image received.One image received from the customer shows a blistered wound and redness was observed on the patient skin.The report indicated the clinical complication occurred post procedure.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8559934
MDR Text Key143380286
Report Number9612164-2019-01493
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2019
Device Catalogue NumberSP-101
Device Lot Number48521
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/24/2019
Initial Date FDA Received04/29/2019
Supplement Dates Manufacturer Received05/09/2019
Supplement Dates FDA Received05/27/2019
Date Device Manufactured08/21/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-